ACA vs AII

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 28, 2026

ACA

53.6
AI Score
VS
ACA Wins

AII

49.2
AI Score

Investment Advisor Scores

ACA

54score
Recommendation
HOLD

AII

49score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ACA AII Winner
Revenue 571.70M 90.93M ACA
Net Income 37.80M 19.91M ACA
Net Margin 6.6% 21.9% AII
ROE 1.4% 5.9% AII
ROA 0.8% 1.7% AII
Total Assets 5.00B 1.18B ACA
Cash 153.20M 171.18M AII
Free Cash Flow 28.40M 5.53M ACA

Relative Price Performance (Last 90 Days)

ACA 1M: +0.4% · 3M: +14.8% AII 1M: +6.6% · 3M: +3.5%

Current Technical Phase

ACA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.4% over 20 days), RSI 66

RSI (14): 66.1 · Price: $145.20

AII

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 66

RSI (14): 65.9 · Price: $20.29

Fundamentals Snapshot

Metric ACA AII
Market Cap
Forward P/E 28.6 6.7
Trailing P/E 32.4 4.2
Revenue (TTM)
Revenue Growth 0.0% 0.3%
Gross Margin 0.2% 0.5%
Operating Margin 0.1% 0.3%
EPS 4.48 4.82
Dividend Yield 0.00% 0.00%

Frequently Asked Questions

Based on our detailed analysis, ACA is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.